Prospera Financial Services Inc Karuna Therapeutics, Inc. Transaction History

Prospera Financial Services Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $125,587 - $247,923	780 New	780 $246,000
Q4 2022 Feb 08, 2023	BUY	$191.53 - $236.82 $214,705 - $265,475	1,121 New	1,121 $220,000
Q2 2022 Aug 08, 2022	SELL	$93.97 - $143.33 $162,004 - $247,100	-1,724 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$98.9 - $132.37 $16,318 - $21,841	-165 Reduced 8.73%	1,724 $219,000
Q3 2021 Nov 12, 2021	BUY	$101.2 - $125.87 $6,982 - $8,685	69 Added 3.79%	1,889 $231,000
Q2 2021 Aug 12, 2021	BUY	$107.45 - $135.95 $195,559 - $247,428	1,820 New	1,820 $207,000
Q4 2020 Feb 12, 2021	SELL	$75.23 - $109.23 $70,866 - $102,894	-942 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$71.31 - $109.74 $67,174 - $103,375	942 New	942 $73,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.